Trial NCT01949870

View at ClinicalTrials.gov 
Org. Study IDs: D1532C00075

Last trial update was posted on 2016-05-13

MeSH Interventions

Gemcitabine

MeSH Conditions

Biliary Tract Neoplasms

Other Conditions

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer

Stopping Reasons

change in the development strategy

Limitations And Caveats

Dose escalation stopped after the first cohort due to changes in the drug development strategy. As such, a non-tolerated dose was not determined and the maximum tolerated dose could not be confirmed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID